NOTE TO JOURNALISTS:
Photos of Susan Hardin at work are available on the Web at http://www.uh.edu/media/nr/2004/03mar/shardin_photo.html.
A high-resolution photo is available by contacting Lisa Merkl.
‘TOP HOUSTON WOMEN IN TECHNOLOGY’
HONOREE AT UH
Professor Susan Hardin Recognized for Contributions in BioNano Technology
HOUSTON, March 26, 2004 – Susan H. Hardin, an associate
professor of biology and biochemistry at the University of Houston,
has been chosen one of Houston’s top women in technology.
Hardin will be recognized with a group of her peers at a gala June
12 when she receives one of the “Top Houston Women in Technology”
awards for 2004.
This year’s awards mark the 25th anniversary of the Association
for Women in Computing (AWC), a national organization dedicated
to helping women advance and achieve leadership roles in the technical
disciplines of computing, business, industry, science, education
and government. The 22 honorees of 2004 represent an array of leaders
in Houston, from the corporate sector to non-profits and academic
institutions, each having demonstrated significant accomplishments
in her career and acting as a positive role model for women.
Hardin received her bachelor’s degree in biology from Penn
State University in 1982 and her doctorate in molecular, cellular
and developmental biology from Indiana University in 1987. Her postdoctoral
work at Brandeis University helped launched her career. Joining
the UH faculty in 1995, Hardin’s research interests are in
the areas of molecular genetics and biotechnology, especially with
respect to the mechanisms of enzymatic DNA synthesis and DNA replication.
Hardin also is president and CEO of VisiGen Biotechnologies Inc.,
one of Houston’s leading-edge BioNano Technology companies,
co-founding it with four other UH professors. Her work is enabling
new platform technologies to revolutionize biomolecular sequencing.
This research has led to the development of a new technology for
direct molecular sensing that can be used to sequence an entire
genome – the genetic code in a person’s DNA –
in less than 24 hours at a reasonable cost, thereby enabling personalized
medicine.
“Dr. Hardin’s contributions are a prime example of
UH’s commitment to biomedical research,” said John Bear,
dean of UH’s College of Natural Sciences and Mathematics.
“The technologies she and her colleagues are developing may
soon offer physicians a quicker, more thorough way to assess genetically
linked risk factors for such things as diseases and adverse drug
reactions.”
About the University of Houston
The University of Houston, Texas’ premier metropolitan research
and teaching institution, is home to more than 40 research centers
and institutes and sponsors more than 300 partnerships with corporate,
civic and governmental entities. UH, the most diverse research university
in the country, stands at the forefront of education, research and
service with more than 35,000 students.
For more information about the AWC’s “Top Houston Women
in Technology” award, visit http://awchouston.org/gala%202004/2004.htm
To receive UH science news via e-mail, visit http://www.uh.edu/admin/media/sciencelist.html
For more information about UH visit the universitys Newsroom at www.uh.edu/admin/media/newsroom.
|